Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists
Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin · 2023
Read Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists by Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10689439.txt.
Description
Takhyeon Kweon and co-authors weigh two kinds of stomach drugs against kidney risk in a 2023 study. One kind, taken by vast numbers for heartburn and ulcers, had been linked in past work to long-term kidney loss. The other kind is an older rival drug used for the same ills.
The team mined a national health sample and records from six hospitals, matching like patients across drug groups. Rates of new kidney loss came out much the same for both drugs. A pooled check across the hospital sets showed no clear added risk for the first drug. The results calm one fear, though such record studies cannot end the debate.
Catalog record
| CREATOR | Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |